Results 211 to 220 of about 14,053 (266)
Target studies for accelerator-based boron neutron capture therapy
J.R. Powell +3 more
openalex +1 more source
Uptakes of boronophenylalanine in the <i>in vitro</i> and <i>in situ</i> glioblastoma and the potential efficacy of boron neutron capture therapy. [PDF]
Zhang S +14 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Boron and gadolinium neutron capture therapy
Russian Chemical Bulletin, 2004AbstractFor Abstract see ChemInform Abstract in Full Text.
Narayan S Hosmane
exaly +2 more sources
Boron Neutron Capture Therapy for Cancer
Scientific American, 1990Boron neutron capture therapy (BNCT) bring together two components that when kept separate have only minor effects on normal cells. The first component is a stable isotope of boron (boron 10) that can be concentrated in tumor cells. The second is a beam of low-energy neutrons that produces short-range radiation when absorbed, or captured, by the boron.
R F, Barth, A H, Soloway, R G, Fairchild
openaire +3 more sources
Boron neutron capture therapy for glioblastoma
Cancer Letters, 2008Boron neutron capture therapy (BNCT) theoretically allows the preferential destruction of tumor cells while sparing the normal tissue, even if the cells have microscopically spread to the surrounding normal brain. The tumor cell-selective irradiation used in this method is dependent on the nuclear reaction between the stable isotope of boron ((10)B ...
Tetsuya, Yamamoto +2 more
openaire +2 more sources
Microdosimetry for Boron Neutron Capture Therapy
Radiation Research, 1992Preclinical studies for boron neutron capture therapy (BNCT) using epithermal neutrons are ongoing at several laboratories. The absorbed dose in tumor cells is a function of the thermal neutron flux at depth, the microscopic boron concentration, and the size of the cell.
C S, Wuu +4 more
openaire +2 more sources
Physics of Atomic Nuclei, 2021
Fundamentals of boron neutron capture therapy of malignant tumors are outlined, and the current status of the development of epithermal-neutron sources on the basis of charged-particle accelerators is surveyed. Attention is additionally given to a neutron source based on a charged-particle accelerator belonging to a new type—a tandem accelerator with ...
openaire +1 more source
Fundamentals of boron neutron capture therapy of malignant tumors are outlined, and the current status of the development of epithermal-neutron sources on the basis of charged-particle accelerators is surveyed. Attention is additionally given to a neutron source based on a charged-particle accelerator belonging to a new type—a tandem accelerator with ...
openaire +1 more source
Utilizing neutron generators in boron neutron capture therapy
Applied Radiation and Isotopes, 2021Neutron capture therapy (NCT) is a radiotherapeutic technique that is designed to utilize the neutron capture reaction and damage the tumor cells through the energy release from the reaction. Nuclear reactors are typically utilized in this therapy because of the high neutron fluence rate that can be achieved. There has been minimal work to evaluate the
Walid A, Metwally +3 more
openaire +2 more sources
Ligand Liposomes and Boron Neutron Capture Therapy
Journal of Neuro-Oncology, 2003Boron neutron capture therapy (BNCT) has been used both experimentally and clinically for the treatment of gliomas and melanomas, with varying results. However, the therapeutic effects on micro-invasive tumor cells are not clear. The two drugs that have been used clinically, p-boronophenylalanine, (BPA), and the sulfhydryl borane, (BSH), seem to be ...
Jörgen, Carlsson +5 more
openaire +2 more sources
Fractionation in Boron Neutron Capture Therapy
1989The theoretical basis has been described for the value of BNCT in the treatment of cerebral glioblastoma multiforme.1 Early clinical trials in the United States showed unexpected and excessive damage to normal brain tissue. Subsequent analysis suggests that this damage was due to high levels of boron in blood at the time of irradiation.
K R, Durrant, J, Hopewell
openaire +2 more sources

